University of Cambridge > Talks.cam > Cambridge Biomedical Research Centre "Distinguished Visitors" 2017 Lecture Series > Hematopoietic stem cell gene therapy in inherited monogenic diseases entering clinical health care

Hematopoietic stem cell gene therapy in inherited monogenic diseases entering clinical health care

Add to your list(s) Download to your calendar using vCal

  • UserProf Gerard Wagemaker - Emeritus Professor of Haematology, Chair of Stem Cell Gene Therapy of Erasmus University Medical Center, Rotterdam
  • ClockThursday 02 February 2017, 17:00-18:00
  • HouseClifford Allbutt Lecture Theatre.

If you have a question about this talk, please contact Sylvie Robinson.

Book your free ticket on https://www.eventbrite.com/e/cambridge-brc-distinguished-visitors-lecture-series-2017-gerard-wagemaker-tickets-30356352668

Gerard Wagemaker was trained in medicine, and in radiation, transplantation and stem cell biology. His current research focuses on stem cell regulation by hematopoietic cytokines and on preclinical evaluation of gene therapy for inherited immune deficiencies, lysosomal enzyme storage diseases and mitochondrial disorders. He has a long record as coordinator of European collaborative projects in the EURATOM and Health areas, in the ‘90s evaluated the health consequences of the Chernobyl accident for the Dutch government and for EURATOM , from 2001-2010 coordinated the European Commission’s collaborative research projects on stem cell gene therapy for monogenic inherited diseases and till 2016 participated in these projects. From 2007-2008 and 2011-2012 he was Visiting Professor of Molecular Cell Biology at the Weizmann Institute, Israel, and is currently professor at the stem cell transplant centers of Pavlov State Medical University, St. Petersburg, Russia, supported by the Gorbachov Foundation, and of the Children’s Hospital of Hacettepe Medical University, Ankara, which is the national referral hospital for rare diseases in Turkey. He has been a member of the European Union Committee of Experts on Rare Diseases (EUCERD), is President of the Netherlands’ Society of Gene & Cell Therapy (NTVGC) and was recently awarded a doctorate honoris causa by the St. Petersburg Pavlov University.

This talk is part of the Cambridge Biomedical Research Centre "Distinguished Visitors" 2017 Lecture Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity